VIKING GLOBAL INVESTORS LP

SEC Form 4 insider trading activity

VIKING GLOBAL INVESTORS LP has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Oct 9, 2025.

On the most recent filing, VIKING GLOBAL INVESTORS LP is listed as 10% Owner at Inhibrx Biosciences, Inc. Inside the rolling window, VIKING GLOBAL INVESTORS LP reported no open-market purchases and 1 open-market sale totaling $11.3M in INBX.

Companies traded

Other insiders at INBX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$11.3M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
INBX
VIKING GLOBAL INVESTORS LP
Sale$11.3MOct 9SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has VIKING GLOBAL INVESTORS LP made?

VIKING GLOBAL INVESTORS LP has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company since 2025.

Which companies does VIKING GLOBAL INVESTORS LP trade?

VIKING GLOBAL INVESTORS LP has filed SEC Form 4 disclosures for 1 company, including INBX.

When was VIKING GLOBAL INVESTORS LP's most recent SEC Form 4 filing?

VIKING GLOBAL INVESTORS LP's most recent SEC Form 4 filing on Tracefour is dated Oct 9, 2025.

What is VIKING GLOBAL INVESTORS LP's total buy and sell value in the current window?

Inside the rolling retention window, VIKING GLOBAL INVESTORS LP bought $0 and sold $11.3M based on SEC Form 4 filings.

What was VIKING GLOBAL INVESTORS LP's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 350,000 INBX shares on 2025-10-07, worth $11.3M, per SEC Form 4 filings.